Media
Latest News
WASHINGTON – Congressman Morgan Luttrell (R-TX), Chairman of the House Veterans Affairs Committee’s (HVAC) Subcommittee on Disability Assistance and Memorial Affairs (DAMA) sent a letter to U.S.
Lawmakers and advocates have launched a full-court press for federal approval of the psychedelic drug MDMA to treat post-traumatic stress disorder after an advisory panel recommended against the therapy last month.
WASHINGTON – Congressman Morgan Luttrell (R-TX) this week voted in favor of the Fiscal Year 2025 (FY25) Defense Appropriations Act, a legislative package aimed at bolstering America’s military readiness, deterring adversaries, and supporting military personnel and their families.
WASHINGTON – Congressman Morgan Luttrell (R-TX) today voted in support of the Fiscal Year 2025 (FY25) Homeland Security Appropriations Act, a comprehensive bill to secure our Southern and Northern Borders and address the ongoing border crisis that has jeopardized the safety and security of every American.
WASHINGTON — Lawmakers urged the Department of Veterans Affairs to take more steps to reduce a backlog of claims from disabled veterans and their survivors seeking health care services and benefits, which peaked at more than 400,000 in January.
WASHINGTON – Congressman Morgan Luttrell (R-TX), a member of the House Armed Services Committee (HASC), today voted in favor of H.R. 8070, the Servicemember Quality of Life Improvement and National Defense Authorization Act (NDAA) for Fiscal Year 2025 (FY25). The legislation passed out of the House 217-199.
In recent years, a quiet revolution has been unfolding within the realm of treatment for combat-related injuries: psychedelic therapies. Substances like MDMA, psilocybin and ibogaine are now at the forefront of cutting-edge research for their potential to alleviate severe conditions, particularly post-traumatic stress (PTS) and post-traumatic stress disorder (PTSD).
In recent years, a quiet revolution has been unfolding within the realm of treatment for combat-related injuries: psychedelic therapies. Substances like MDMA, psilocybin and ibogaine are now at the forefront of cutting-edge research for their potential to alleviate severe conditions, particularly post-traumatic stress (PTS) and post-traumatic stress disorder (PTSD).
WASHINGTON — House lawmakers on Tuesday demanded the resignation of Shereef Elnahal, undersecretary for health at the Department of Veterans Affairs, for withholding information from the VA secretary about plans to give large bonuses to senior managers meant for rank-and-file workers.